-
1
-
-
0005058478
-
Medullary thyroid carcinoma
-
Editions Nucleon Paris, Chapter
-
Schlumberger M, Pacini F. Medullary thyroid carcinoma. In: Thyroid tumors, Editions Nucleon Paris, 1999; Chapter 15, 267-299.
-
(1999)
Thyroid Tumors
, vol.15
, pp. 267-299
-
-
Schlumberger, M.1
Pacini, F.2
-
2
-
-
0024213731
-
Oncological applications of somatostatin analogs
-
Schally AV. Oncological applications of somatostatin analogs. Cancer Res 1988, 48: 6977-6985.
-
(1988)
Cancer Res.
, vol.48
, pp. 6977-6985
-
-
Schally, A.V.1
-
3
-
-
0031784575
-
Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
-
Mato E, Matias-Guiu X, Chico A, et al. Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin End Metab 1998; 83: 2417-2420.
-
(1998)
J. Clin. End. Metab.
, vol.83
, pp. 2417-2420
-
-
Mato, E.1
Matias-Guiu, X.2
Chico, A.3
-
4
-
-
0027336781
-
Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs
-
G. Thieme Verlag, Stuttgart-New York
-
Doerr U, Wurm K, Horing E, et al. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs. In: Somatostatin receptor imaging, hormone and metabolic research, G. Thieme Verlag, Stuttgart-New York 1993; Suppl. 27: 36-43.
-
(1993)
Somatostatin Receptor Imaging, Hormone and Metabolic Research
, vol.27
, Issue.SUPPL.
, pp. 36-43
-
-
Doerr, U.1
Wurm, K.2
Horing, E.3
-
5
-
-
0026041670
-
The role of somatostatin and its analogs in the diagnosis and treatment of tumors
-
Lamberts S, Krenning E, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rew 1991; 12: 450-482.
-
(1991)
Endocr. Rew.
, vol.12
, pp. 450-482
-
-
Lamberts, S.1
Krenning, E.2
Reubi, J.C.3
-
7
-
-
0026378464
-
Somatostatin receptors and somatostatin content in medullary thyroid carcinomas
-
Reubi JC, Chayvialle JA, Franc B, et al. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 1991; 64: 567-573.
-
(1991)
Lab. Invest.
, vol.64
, pp. 567-573
-
-
Reubi, J.C.1
Chayvialle, J.A.2
Franc, B.3
-
8
-
-
0025835957
-
Radionuclide therapy revisited
-
Hoefnagel CA. Radionuclide therapy revisited. Eur J Nucl Med 1991; 18: 408-431.
-
(1991)
Eur. J. Nucl. Med.
, vol.18
, pp. 408-431
-
-
Hoefnagel, C.A.1
-
9
-
-
0035119335
-
Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units
-
Dotzenrath C, Goretzki P, Cupisti K, et al. Is there any consensus in diagnostic and operative strategy with respect to medullary thyroid cancer? A questionnaire answered by 73 endocrine surgical units. Langenbeck's Arch Surg 2001; 386: 47-52.
-
(2001)
Langenbeck's Arch. Surg.
, vol.386
, pp. 47-52
-
-
Dotzenrath, C.1
Goretzki, P.2
Cupisti, K.3
-
10
-
-
0035027708
-
Effect of octreotide on proliferation of in vitro cultured thyroid medullary carcinoma cells
-
Zabel M, Gebarowska E, Drag-Zalesinska M, et al. Effect of octreotide on proliferation of in vitro cultured thyroid medullary carcinoma cells. Folia Histoch et Cytobiol 2001; 39: 185-186.
-
(2001)
Folia Histoch. Et Cytobiol.
, vol.39
, pp. 185-186
-
-
Zabel, M.1
Gebarowska, E.2
Drag-Zalesinska, M.3
-
11
-
-
0009708761
-
Theory and practice of clinical trials
-
Holland JF, Frei III E, Bast Jr RC, et al (eds), 3rd edn, Lea & Febiger, Philadelphia-London; Chapter V, 1993
-
Zelen M. Theory and practice of clinical trials. In: Cancer medicine, Holland JF, Frei III E, Bast Jr RC, et al (eds), 3rd edn, Lea & Febiger, Philadelphia-London; 1993, Chapter V, pp 340-360, 1993.
-
(1993)
Cancer Medicine
, pp. 340-360
-
-
Zelen, M.1
-
12
-
-
0033503932
-
Patterns of nodal metastases in palpable medullary thyroid cancer
-
Molley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid cancer. Ann Surg 1999; 229: 880-888.
-
(1999)
Ann. Surg.
, vol.229
, pp. 880-888
-
-
Molley, J.F.1
DeBenedetti, M.K.2
-
13
-
-
0029681098
-
Langzeiterlauf des medullaeren Schilddruesenkarzinomes
-
Wagner HE, Ruchti C, Studer M, et al. Langzeiterlauf des medullaeren Schilddruesenkarzinomes. Swiss Surg 1996; 2: 181-186.
-
(1996)
Swiss Surg.
, vol.2
, pp. 181-186
-
-
Wagner, H.E.1
Ruchti, C.2
Studer, M.3
-
14
-
-
12544251995
-
Calcitonin (CT) stimulation tests in the diagnosis and follow up of patients with medullary thyroid carcinoma (MTC)
-
Amsterdam/The Netherlands, September 5-19
-
Vainas I, Votsi M, Atmatzidis E, et al. Calcitonin (CT) stimulation tests in the diagnosis and follow up of patients with medullary thyroid carcinoma (MTC). Proceedings of Fourth International Congress on Hormones and Cancer, Amsterdam/The Netherlands, September 5-19, 1991: 379.
-
(1991)
Proceedings of Fourth International Congress on Hormones and Cancer
, pp. 379
-
-
Vainas, I.1
Votsi, M.2
Atmatzidis, E.3
-
15
-
-
0035078566
-
Octreotide in the management of hormone refractory prostate cancer
-
Vainas I. Octreotide in the management of hormone refractory prostate cancer. Chemotherapy 2001; 47, Suppl. 2: 109-126,
-
(2001)
Chemotherapy
, vol.47
, Issue.SUPPL. 2
, pp. 109-126
-
-
Vainas, I.1
-
17
-
-
0022878517
-
Somatostatin analog: Effects on hypergastrinemia and hypercalcitoninemia
-
Geelhood GW, Bass BL, Mertz SL, et al. Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia. Surgery 1986; 100: 962-970.
-
(1986)
Surgery
, vol.100
, pp. 962-970
-
-
Geelhood, G.W.1
Bass, B.L.2
Mertz, S.L.3
-
18
-
-
0023181206
-
Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion. A new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995
-
Jerkins TW, Sacks HS, O'Dorisio TM, et al. Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion. A new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab 1987; 64: 13413-13419.
-
(1987)
J. Clin. Endocrinol. Metab.
, vol.64
, pp. 13413-13419
-
-
Jerkins, T.W.1
Sacks, H.S.2
O'Dorisio, T.M.3
-
19
-
-
0022529091
-
Treatment of APUDomas with long acting somatostatin analogue SMS 201-995
-
Schrezemeir J, Plewe G Sturmer W et al. Treatment of APUDomas with long acting somatostatin analogue SMS 201-995. Scand J Gastroenterol 1986; 119: 223-227.
-
(1986)
Scand. J. Gastroenterol.
, vol.119
, pp. 223-227
-
-
Schrezemeir, J.1
Plewe, G.2
Sturmer, W.3
-
20
-
-
0024520252
-
Somatostatin in medullary thyroid cancer - In vitro and in vivo studies
-
Pacini F, Elisei R, Anelli S, et al. Somatostatin in medullary thyroid cancer - in vitro and in vivo studies. Cancer 1989; 63:1189-1195.
-
(1989)
Cancer
, vol.63
, pp. 1189-1195
-
-
Pacini, F.1
Elisei, R.2
Anelli, S.3
-
21
-
-
0018090610
-
Somatostatin inhibits the pentagastrin induced release of serum calcitonin in medullary carcinoma of the thyroid
-
Gordin A, Lamberg BA, Pelkonen A, et al. Somatostatin inhibits the pentagastrin induced release of serum calcitonin in medullary carcinoma of the thyroid. Clin Endocrinol 1987; 8: 289-293.
-
(1987)
Clin. Endocrinol.
, vol.8
, pp. 289-293
-
-
Gordin, A.1
Lamberg, B.A.2
Pelkonen, A.3
-
22
-
-
0024325236
-
Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma
-
Guliana JM, Guilliausseau PJ, Caron J, et al. Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma. Horm Metabol Res 1989; 21: 584-586.
-
(1989)
Horm. Metabol. Res.
, vol.21
, pp. 584-586
-
-
Guliana, J.M.1
Guilliausseau, P.J.2
Caron, J.3
-
23
-
-
0024951883
-
Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma
-
Libroia A, Verga U, di Sacco G, et al. Use of somatostatin analog SMS 201-995 in medullary thyroid carcinoma. Henry Ford Hosp Med J 1989; 37: 151-153.
-
(1989)
Henry Ford Hosp. Med. J.
, vol.37
, pp. 151-153
-
-
Libroia, A.1
Verga, U.2
di Sacco, G.3
-
24
-
-
0034453062
-
Slow release lanreotide in combination with interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma
-
Vitaie G, Tagliaferri P, Caraglia M, et al. Slow release lanreotide in combination with interferon-a2b in the treatment of symptomatic advanced medullary thyroid carcinoma. J Clin End Metab 2000; 85: 983-988.
-
(2000)
J. Clin. End. Metab.
, vol.85
, pp. 983-988
-
-
Vitaie, G.1
Tagliaferri, P.2
Caraglia, M.3
-
25
-
-
0036796145
-
Somatostatin analogs in the treatment of medullary thyroid carcinoma
-
Diez JJ, Iglesias P. Somatostatin analogs in the treatment of medullary thyroid carcinoma. J Endocrinol Invest 2002; 25: 773-778.
-
(2002)
J. Endocrinol. Invest.
, vol.25
, pp. 773-778
-
-
Diez, J.J.1
Iglesias, P.2
-
26
-
-
0029768847
-
Somatostatin and somatostatin analogues in medullary thyroid carcinoma
-
O'Byrne KJ, O'Hare N, Sweeney E, et al. Somatostatin and somatostatin analogues in medullary thyroid carcinoma. Nucl Med Commun 1996; 17: 810-816.
-
(1996)
Nucl. Med. Commun.
, vol.17
, pp. 810-816
-
-
O'Byrne, K.J.1
O'Hare, N.2
Sweeney, E.3
-
27
-
-
0032980277
-
Quality of life in head and neck patients: Validation of the European Organization for Research and treatment of cancer quality of life questionnaire-H& N35
-
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck patients: Validation of the European Organization for Research and treatment of cancer quality of life questionnaire-H& N35. J Clin Oncol. 1999; 17: 1008.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1008
-
-
Bjordal, K.1
Hammerlid, E.2
Ahlner-Elmqvist, M.3
-
28
-
-
17544405207
-
External radiotherapy of thyroid cancer
-
Pöllinger B, Dühmke E. External radiotherapy of thyroid cancer. Onkologie 2001; 24: 134-138.
-
(2001)
Onkologie
, vol.24
, pp. 134-138
-
-
Pöllinger, B.1
Dühmke, E.2
-
29
-
-
19444371048
-
Combined radioimmunotherapy (RAIT) and chemotherapy (CH) in patients with medullary thyroid cancer (MTC): First clinical results
-
Juweid M, Rubin AD, Hajjar G, et al. Combined radioimmunotherapy (RAIT) and chemotherapy (CH) in patients with medullary thyroid cancer (MTC): first clinical results. Clin Cancer Res (Suppl) 1999; 5.
-
(1999)
Clin. Cancer Res.
, Issue.SUPPL.
, pp. 5
-
-
Juweid, M.1
Rubin, A.D.2
Hajjar, G.3
|